Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.8493
-0.0908 (-9.66%)
At close: Oct 29, 2026, 4:00 PM EDT
0.8301
-0.0192 (-2.26%)
Pre-market: Oct 30, 2026, 7:35 AM EDT
Celularity Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18.67 | 26.55 | 54.22 | 22.77 | 17.98 | 21.34 | |
Revenue Growth | -58.14% | -51.03% | 138.11% | 26.68% | -15.75% | 49.43% |
Cost of Revenue | 15.08 | 20.07 | 14.99 | 16.02 | 19.67 | 9.65 |
Gross Profit | 3.59 | 6.48 | 39.23 | 6.76 | -1.69 | 11.68 |
Selling, General & Admin | 38.48 | 51.27 | 58.64 | 50.58 | 66.02 | 62.21 |
Research & Development | 12.97 | 15.03 | 17.39 | 30.47 | 78.36 | 84.97 |
Amortization of Goodwill & Intangibles | - | -0.42 | 1.75 | 2.19 | 2.19 | 2.19 |
Operating Expenses | 51.01 | 65.87 | 77.78 | 83.23 | 146.58 | 149.37 |
Operating Income | -47.42 | -59.4 | -38.55 | -76.48 | -148.27 | -137.69 |
Interest Expense | -2.9 | -6.75 | -6.26 | -3.02 | - | -3.17 |
Interest & Investment Income | 0.2 | 0.26 | 0.33 | 0.32 | 0.37 | 0.33 |
Other Non Operating Income (Expenses) | 10.19 | -13.43 | -9.2 | -0.13 | 41.96 | 11.8 |
EBT Excluding Unusual Items | -39.94 | -79.31 | -53.69 | -79.3 | -105.94 | -128.72 |
Merger & Restructuring Charges | - | - | - | - | - | -7.19 |
Impairment of Goodwill | - | - | - | -112.35 | -3.61 | - |
Gain (Loss) on Sale of Investments | -2.89 | -2.89 | - | - | - | - |
Legal Settlements | - | - | - | - | - | -5.33 |
Other Unusual Items | -3.03 | -9.51 | -4.21 | 103.16 | 123.76 | 41.15 |
Pretax Income | -45.86 | -91.71 | -57.89 | -196.29 | 14.21 | -100.1 |
Income Tax Expense | 0 | 0 | - | 0.01 | 0.01 | 0.02 |
Net Income | -45.86 | -91.72 | -57.89 | -196.3 | 14.19 | -100.12 |
Preferred Dividends & Other Adjustments | 0.38 | 0.08 | - | - | - | - |
Net Income to Common | -46.24 | -91.8 | -57.89 | -196.3 | 14.19 | -100.12 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 28 | 26 | 22 | 18 | 14 | 7 |
Shares Outstanding (Diluted) | 28 | 26 | 22 | 18 | 15 | 7 |
Shares Change | 23.65% | 16.94% | 22.89% | 18.89% | 123.44% | 264.09% |
EPS (Basic) | -1.63 | -3.59 | -2.64 | -11.02 | 1.01 | -14.93 |
EPS (Diluted) | -1.63 | -3.59 | -2.64 | -11.02 | 0.95 | -14.93 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.92 | -13.25 | -6.56 | -39.73 | -143.11 | -116.3 |
Free Cash Flow Per Share | -0.31 | -0.52 | -0.30 | -2.23 | -9.55 | -17.34 |
Gross Margin | 19.23% | 24.39% | 72.36% | 29.67% | -9.40% | 54.75% |
Operating Margin | -254.03% | -223.72% | -71.10% | -335.86% | -824.85% | -645.35% |
Profit Margin | -247.71% | -345.76% | -106.77% | -862.04% | 78.95% | -469.27% |
Free Cash Flow Margin | -47.80% | -49.92% | -12.10% | -174.49% | -796.17% | -545.11% |
EBITDA | -42.57 | -54.01 | -30.63 | -67.16 | -138.83 | -128.87 |
EBITDA Margin | -228.03% | -203.44% | -56.49% | -294.91% | - | - |
D&A For EBITDA | 4.85 | 5.38 | 7.92 | 9.32 | 9.44 | 8.82 |
EBIT | -47.42 | -59.4 | -38.55 | -76.48 | -148.27 | -137.69 |
EBIT Margin | -254.03% | -223.72% | -71.10% | - | - | - |
Effective Tax Rate | - | - | - | - | 0.09% | - |
Revenue as Reported | 18.67 | 26.55 | 54.22 | 22.77 | 17.98 | 21.34 |